Search research articles
Contact Us
Filters
Showing results (711-720 of 874) with videos related to
Page
of 88
Sort By:
The Journal of Infectious Diseases
|
April 1, 1994
Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations
R W Shafer, M J Kozal, M A Winters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2004
Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma
Howard M Katzenstein, Susan L Cohn, Richard M Shore, et al.
The Journal of Infectious Diseases
|
June 1, 1996
A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with > or = 400/mm3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137)
F T Valentine, S Kundu, P A Haslett, et al.
Radiology
|
September 1, 1986
Calcification in pulmonary nodules: detection with dual-energy digital radiography
R G Fraser, N M Hickey, L T Niklason, et al.
Nutrients
|
April 12, 2022
Correlates of Pancreatic Enzyme Replacement Therapy Intake in Adults with Cystic Fibrosis: Results of a Cross-Sectional Study
Mette F Olsen, Maria S Kjøller-Svarre, Grith Møller, et al.
Journal of Acquired Immune Deficiency Syndromes
|
January 1, 1990
Clinical and laboratory characteristics of HIV-1 infection in Zimbabwe
D A Katzenstein, A S Latif, S A Grace, et al.
Journal of Virology
|
March 20, 2009
CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic
Awet Abraha, Immaculate L Nankya, Richard Gibson, et al.
Pediatric Blood & Cancer
|
September 17, 2019
Proton therapy following induction chemotherapy for pediatric and adolescent nasopharyngeal carcinoma
Haruka Uezono, Daniel J Indelicato, Ronny L Rotondo, et al.
Antimicrobial Agents and Chemotherapy
|
November 26, 2014
Impact of drug resistance-associated amino acid changes in HIV-1 subtype C on susceptibility to newer nonnucleoside reverse transcriptase inhibitors
Adriaan E Basson, Soo-Yon Rhee, Chris M Parry, et al.
HIV Medicine
|
September 15, 2015
Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker of myocardial infarction in HIV-1-infected patients: a nested case-control study
L J H Rasmussen, A Knudsen, T L Katzenstein, et al.
Page
of 88
Search research articles
Search
Showing results (711-720 of 874) with videos related to
Sort By:
Page
of 88
The Journal of Infectious Diseases
|
April 1, 1994
Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations
R W Shafer, M J Kozal, M A Winters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2004
Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma
Howard M Katzenstein, Susan L Cohn, Richard M Shore, et al.
The Journal of Infectious Diseases
|
June 1, 1996
A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with > or = 400/mm3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137)
F T Valentine, S Kundu, P A Haslett, et al.
Radiology
|
September 1, 1986
Calcification in pulmonary nodules: detection with dual-energy digital radiography
R G Fraser, N M Hickey, L T Niklason, et al.
Nutrients
|
April 12, 2022
Correlates of Pancreatic Enzyme Replacement Therapy Intake in Adults with Cystic Fibrosis: Results of a Cross-Sectional Study
Mette F Olsen, Maria S Kjøller-Svarre, Grith Møller, et al.
Journal of Acquired Immune Deficiency Syndromes
|
January 1, 1990
Clinical and laboratory characteristics of HIV-1 infection in Zimbabwe
D A Katzenstein, A S Latif, S A Grace, et al.
Journal of Virology
|
March 20, 2009
CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic
Awet Abraha, Immaculate L Nankya, Richard Gibson, et al.
Pediatric Blood & Cancer
|
September 17, 2019
Proton therapy following induction chemotherapy for pediatric and adolescent nasopharyngeal carcinoma
Haruka Uezono, Daniel J Indelicato, Ronny L Rotondo, et al.
Antimicrobial Agents and Chemotherapy
|
November 26, 2014
Impact of drug resistance-associated amino acid changes in HIV-1 subtype C on susceptibility to newer nonnucleoside reverse transcriptase inhibitors
Adriaan E Basson, Soo-Yon Rhee, Chris M Parry, et al.
HIV Medicine
|
September 15, 2015
Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker of myocardial infarction in HIV-1-infected patients: a nested case-control study
L J H Rasmussen, A Knudsen, T L Katzenstein, et al.
Page
of 88